Reconstruction of the aorto-iliac segment in occlusive disease using the AFX unibody graft
© 2020 Royal Australasian College of Surgeons..
BACKGROUND: The endovascular era has evolved the treatment of aorto-iliac occlusive disease (AIOD). Many institutions now use minimally invasive techniques including kissing iliac stents and covered endovascular reconstruction of the aortic bifurcation. These negate the high morbidity of open surgical reconstruction but do not allow for a crossover approach to treat infra-inguinal disease. The AFX stent does both by anatomically reconstructing the bifurcation in AIOD despite being marketed for aneurysmal aortic disease. This large, single-centre case series assesses the outcomes of treatment of AIOD using the AFX stent.
METHODS: Patients with AIOD who presented to our institution between September 2016 and August 2018 were considered for AFX stenting if kissing iliac stents extending into the aorta or aortobifemoral bypass was required. Patient, treatment and outcome data were recorded with a primary outcome of primary patency at 12 months.
RESULTS: AFX stenting was performed in 29 patients, with an average age of 69 years, 52% (15/29) patients had critical limb ischaemia. Technical success occurred in 100% of patients with clinical success in 96% (28/29). There were no cases of 30 day and 3 (10%) cases of 12 month mortality, 2 (7%) major and 7 (24%) minor complications arose. Median length of stay was 3 days. Primary patency at 12 months was 100% (n = 24).
CONCLUSION: AFX stenting is a safe with satisfactory early results for the treatment of AIOD. The minimally invasive technique and preservation of cross-over approach makes AFX stenting a considered option for the treatment of AIOD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:90 |
|---|---|
| Enthalten in: |
ANZ journal of surgery - 90(2020), 12 vom: 21. Dez., Seite 2496-2501 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Arnold, Angie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aorto-iliac bifurcation |
|---|
| Anmerkungen: |
Date Completed 14.05.2021 Date Revised 14.05.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ans.16236 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314040552 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314040552 | ||
| 003 | DE-627 | ||
| 005 | 20231225151856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ans.16236 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1046.xml |
| 035 | |a (DE-627)NLM314040552 | ||
| 035 | |a (NLM)32830429 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Arnold, Angie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reconstruction of the aorto-iliac segment in occlusive disease using the AFX unibody graft |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.05.2021 | ||
| 500 | |a Date Revised 14.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Royal Australasian College of Surgeons. | ||
| 520 | |a BACKGROUND: The endovascular era has evolved the treatment of aorto-iliac occlusive disease (AIOD). Many institutions now use minimally invasive techniques including kissing iliac stents and covered endovascular reconstruction of the aortic bifurcation. These negate the high morbidity of open surgical reconstruction but do not allow for a crossover approach to treat infra-inguinal disease. The AFX stent does both by anatomically reconstructing the bifurcation in AIOD despite being marketed for aneurysmal aortic disease. This large, single-centre case series assesses the outcomes of treatment of AIOD using the AFX stent | ||
| 520 | |a METHODS: Patients with AIOD who presented to our institution between September 2016 and August 2018 were considered for AFX stenting if kissing iliac stents extending into the aorta or aortobifemoral bypass was required. Patient, treatment and outcome data were recorded with a primary outcome of primary patency at 12 months | ||
| 520 | |a RESULTS: AFX stenting was performed in 29 patients, with an average age of 69 years, 52% (15/29) patients had critical limb ischaemia. Technical success occurred in 100% of patients with clinical success in 96% (28/29). There were no cases of 30 day and 3 (10%) cases of 12 month mortality, 2 (7%) major and 7 (24%) minor complications arose. Median length of stay was 3 days. Primary patency at 12 months was 100% (n = 24) | ||
| 520 | |a CONCLUSION: AFX stenting is a safe with satisfactory early results for the treatment of AIOD. The minimally invasive technique and preservation of cross-over approach makes AFX stenting a considered option for the treatment of AIOD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a aorto-iliac bifurcation | |
| 650 | 4 | |a endovascular treatment | |
| 650 | 4 | |a occlusive disease | |
| 650 | 4 | |a peripheral artery disease | |
| 650 | 4 | |a peripheral vascular disease | |
| 700 | 1 | |a Delaney, Christopher L |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Yew T |e verfasserin |4 aut | |
| 700 | 1 | |a Wise, Nadia |e verfasserin |4 aut | |
| 700 | 1 | |a Puckridge, Phillip J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ANZ journal of surgery |d 2001 |g 90(2020), 12 vom: 21. Dez., Seite 2496-2501 |w (DE-627)NLM110804864 |x 1445-2197 |7 nnns |
| 773 | 1 | 8 | |g volume:90 |g year:2020 |g number:12 |g day:21 |g month:12 |g pages:2496-2501 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ans.16236 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 90 |j 2020 |e 12 |b 21 |c 12 |h 2496-2501 | ||